These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of early effects of budesonide/formoterol maintenance and reliever therapy with fluticasone furoate/vilanterol for asthma patients requiring step-up from inhaled corticosteroid monotherapy. Hozawa S, Terada M, Haruta Y, Hozawa M. Pulm Pharmacol Ther; 2016 Apr; 37():15-23. PubMed ID: 26850307 [Abstract] [Full Text] [Related]
4. Switching from salmeterol/fluticasone to formoterol/budesonide combinations improves peripheral airway/alveolar inflammation in asthma. Akamatsu T, Shirai T, Kato M, Yasui H, Hashimoto D, Fujisawa T, Tsuchiya T, Inui N, Suda T, Chida K. Pulm Pharmacol Ther; 2014 Feb; 27(1):52-6. PubMed ID: 23583566 [Abstract] [Full Text] [Related]
5. Comparison between montelukast and tiotropium as add-on therapy to inhaled corticosteroids plus a long-acting β2-agonist in for patients with asthma. Hoshino M, Akitsu K, Ohtawa J. J Asthma; 2019 Sep; 56(9):995-1003. PubMed ID: 30212239 [Abstract] [Full Text] [Related]
6. Real-world effects of two inhaled corticosteroid/long-acting β₂-agonist combinations in the treatment of asthma. Yatera K, Yamasaki K, Nishida C, Noguchi S, Oda K, Akata K, Nagata S, Kawanami Y, Kawanami T, Ishimoto H, Mukae H. J Asthma; 2014 Sep; 51(7):762-8. PubMed ID: 24654703 [Abstract] [Full Text] [Related]
7. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma. Blanchette CM, Culler SD, Ershoff D, Gutierrez B. Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003 [Abstract] [Full Text] [Related]
9. Difference in time-course of improvement in asthma control measures between budesonide and budesonide/formoterol. Matsunaga K, Kawabata H, Hirano T, Sugiura H, Minakata Y, Ichinose M. Pulm Pharmacol Ther; 2013 Apr; 26(2):189-94. PubMed ID: 23123925 [Abstract] [Full Text] [Related]
10. Achieving asthma control with ICS/LABA: A review of strategies for asthma management and prevention. Aalbers R, Vogelmeier C, Kuna P. Respir Med; 2016 Feb; 111():1-7. PubMed ID: 26614594 [Abstract] [Full Text] [Related]
11. Combination inhaled corticosteroids and long-acting beta2-agonists for children and adults with bronchiectasis. Goyal V, Chang AB. Cochrane Database Syst Rev; 2014 Jun 10; 2014(6):CD010327. PubMed ID: 24913725 [Abstract] [Full Text] [Related]
14. Efficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with asthma: a randomized, controlled trial. Zangrilli J, Mansfield LE, Uryniak T, O'Brien CD. Ann Allergy Asthma Immunol; 2011 Sep 10; 107(3):258-65.e2. PubMed ID: 21875546 [Abstract] [Full Text] [Related]
15. Effects of beclomethason/formoterol and budesonide/formoterol fixed combinations on lung function and airway inflammation in patients with mild to moderate asthma--an exploratory study. Kirsten AM, Watz H, Brindicci C, Piccinno A, Magnussen H. Pulm Pharmacol Ther; 2015 Apr 10; 31():79-84. PubMed ID: 25194884 [Abstract] [Full Text] [Related]
18. Asthma control in adult patients treated with a combination of inhaled corticosteroids and long‑acting β2‑agonists: a prospective observational study. Rogala B, Majak P, Glück J, Dębowski T. Pol Arch Intern Med; 2017 Jan 18; 127(2):100-106. PubMed ID: 28220767 [Abstract] [Full Text] [Related]